US 12258316
Biphenyl compounds useful as muscarinic receptor antagonists
granted A61KA61K31/4545A61K45/06
Quick answer
US patent 12258316 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance Biopharma R&D IP, LLC expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/4545, A61K45/06, A61K9/124, A61K9/1623